Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| FAVRILLE INC | 1,000,000 | reported | 12 May 2016 | tx 24+16,644,207 |
| SUNESIS PHARMACEUTICALS INC | 839,741 | reported | 25 Nov 2024 | tx 34+1,262,121−350,804 |
| Syndax Pharmaceuticals Inc | 625,545 | reported | 20 Mar 2017 | tx 9+758,545−725,545 |
| CORAUTUS GENETICS INC | 87,769 | reported | 11 May 2006 | tx 7+119,678 |
| CANCERVAX CORP | 10,000 | reported | 10 Jun 2004 | tx 1+10,000 |
| BIOCEPT INC | 10,000 | reported | 08 Jul 2022 | tx 19+183,638−18,020 |
| AVALON PHARMACEUTICALS INC | 3,528 | reported | 01 Apr 2008 | tx 12+23,359 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Nov 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 25 Nov 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 25 Aug 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 25 Aug 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | SUNESIS PHARMACEUTICALS INC | 50,000 | 0.00 USD | deriv |
| 25 May 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 25 May 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 25 Feb 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 25 Feb 2024 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 25 Nov 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 25 Nov 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 25 Aug 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 25 Aug 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | SUNESIS PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 25 May 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 25 May 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 25 Feb 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 25 Feb 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 25 Nov 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 25 Nov 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 08 Jul 2022 | GRANT_AWARD | BIOCEPT INC | 10,000 | 0.00 USD | deriv |
| 25 Aug 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | |
| 26 Aug 2022 | SALE | SUNESIS PHARMACEUTICALS INC | 13,379 | 4.01 USD | |
| 25 Aug 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD | deriv |
| 25 May 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 25,219 | 0.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 15 Nov 2021.